Insider Stock Trading History of Hastings Paul J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hastings Paul J since year 2005. The trader's CIK number is 1309702. At the time of this reporting, Hastings Paul J is the Chairman & CEO of Oncomed Pharmaceuticals Inc . (stock ticker symbol OMED). See this page for all insider trading activities at Oncomed Pharmaceuticals Inc .

Note that in the past HASTINGS PAUL J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hastings Paul J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-10 OMED Oncomed Pharmaceuticals Inc Sale 1,398 4.25 5,942
2017-08-22 PCRX Pacira Pharmaceuticals, Inc. Sale 1,044 36.15 37,740
2017-04-04 OMED Oncomed Pharmaceuticals Inc Sale 6,473 8.96 58,017
2017-01-05 OMED Oncomed Pharmaceuticals Inc Option Ex 21,369 1.43 30,557
2017-01-06 OMED Oncomed Pharmaceuticals Inc Option Ex 21,369 1.43 30,557
2017-01-05 OMED Oncomed Pharmaceuticals Inc Sale 21,369 8.17 174,606
2017-01-06 OMED Oncomed Pharmaceuticals Inc Sale 21,369 8.52 181,957
2016-06-07 RLYP Relypsa Inc Sale 1,013 19.32 19,573
2016-06-06 PCRX Pacira Pharmaceuticals, Inc. Sale 1,136 46.95 53,335
2016-02-17 PCRX Pacira Pharmaceuticals, Inc. Option Ex 3,000 12.39 37,185
2016-02-17 PCRX Pacira Pharmaceuticals, Inc. Sale 3,000 60.00 180,000
2016-01-06 OMED Oncomed Pharmaceuticals Inc Sale 2,412 21.92 52,875
2015-11-20 PCRX Pacira Pharmaceuticals, Inc. Option Ex 3,000 10.81 32,430
2015-11-20 PCRX Pacira Pharmaceuticals, Inc. Sale 3,000 60.00 180,000
2015-08-17 PCRX Pacira Pharmaceuticals, Inc. Option Ex 3,000 10.81 32,430
2015-08-17 PCRX Pacira Pharmaceuticals, Inc. Sale 3,000 60.02 180,060
2015-06-11 RLYP Relypsa Inc Sale 1,454 34.63 50,359
2015-04-10 PCRX Pacira Pharmaceuticals, Inc. Option Ex 2,500 13.98 34,950
2015-04-10 PCRX Pacira Pharmaceuticals, Inc. Sale 2,500 88.00 220,000
2015-01-12 PCRX Pacira Pharmaceuticals, Inc. Option Ex 2,500 13.98 34,950
2015-01-12 PCRX Pacira Pharmaceuticals, Inc. Sale 2,500 94.06 235,150
2014-10-28 OMED Oncomed Pharmaceuticals Inc Option Ex 8,384 1.43 11,989
2014-10-29 OMED Oncomed Pharmaceuticals Inc Option Ex 8,385 1.43 11,990
2014-10-28 OMED Oncomed Pharmaceuticals Inc Sale 8,384 22.08 185,127
2014-10-29 OMED Oncomed Pharmaceuticals Inc Sale 8,385 21.90 183,614
2014-10-10 PCRX Pacira Pharmaceuticals, Inc. Sale 2,500 94.87 237,175
2014-10-10 PCRX Pacira Pharmaceuticals, Inc. Option Ex 2,500 13.98 34,950
2014-07-28 OMED Oncomed Pharmaceuticals Inc Option Ex 8,385 1.43 11,990
2014-07-29 OMED Oncomed Pharmaceuticals Inc Option Ex 8,385 1.43 11,990
2014-07-28 OMED Oncomed Pharmaceuticals Inc Sale 8,385 22.31 187,102
2014-07-29 OMED Oncomed Pharmaceuticals Inc Sale 8,385 22.28 186,801
2014-07-10 PCRX Pacira Pharmaceuticals, Inc. Option Ex 2,500 13.98 34,950
2014-07-10 PCRX Pacira Pharmaceuticals, Inc. Sale 2,500 84.38 210,957
2013-05-15 PCRX Pacira Pharmaceuticals, Inc. Buy 853 29.30 24,992
2005-04-29 QLTI Qlt Inc/bc Buy 900 10.77 9,693

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hastings Paul J (Chairman & CEO of Oncomed Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.